Medical Waste Treatment Disposal System Patent Claims Allowed

“Since the project’s inception we have identified a $7 billion global market demand for our Interceptor Waste Treatment System™.”

For Immediate Release

Release Date:
Wednesday, August 11, 2010

Knoxville, TN - Innovasan announces patent claims in two pending U.S. patent applications covering their Med-San™ Process were recently allowed and the first two U.S. patents for the Process are expected to issue in September 2010. Corresponding patent applications for the Med-San™ Process are pending in Europe, India, South Korea, Canada, Brazil and Australia.

Med-San™ is a volume scalable, continuous flow process methodology that will destroy both biological and pharmaceutical compounds making the medical waste stream sterile and chemically inert for safe direct discharge into the environment.

"Our military wants the Med-San™ Process for both their mobile and fixed installation medical treatment facilities and we are collaborating with the Telemedicine & Advanced Technology Research Center (TATRC), U.S. Army Medical Research and Materiel Command to build and deploy the Interceptor Waste Treatment System™ Product Line based on our Med-San™ Process," says Ellen Hubrig, President. "Interceptor was conceived in response to a military mission requirement to protect the warfighter from current medical waste disposal practices. Since the project's inception we have identified a $7 billion global market demand for our Interceptor Waste Treatment System™. These are the first patents to issue in our intellectual property portfolio and a cornerstone in our initiative to find a strategic partner to commercialize Interceptor."